Fundraising Fox
/People
Sign in

Carlos Loya

Executive Officer, Director at Aldebaran Therapeutics · Former Venture Partner & Founder at 82VS

Cambridge, Massachusetts, United States

Find your path to Carlos

287 people in our graph can introduce you to Carlos.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Kiran Reddy to introduce you to Carlos

You →Kiran · together at Praxis (2018–2020) →Carlos

Ask Jamie Chen to introduce you to Carlos

You →Jamie · 2 people · together at Praxis →Carlos

Ask Sam Okafor to introduce you to Carlos

You →Sam · 3 people · together at 82VS →Carlos

Sign up to find every way you can get introduced to Carlos

  • Your email: the people you already email who know Carlos
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Carlos
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Carlos Loya is a scientist and biotech executive who served as a founding team member at SAGE Therapeutics and Praxis Precision Medicines, where he contributed to the strategy, discovery, and development of multiple programs including Zulresso™ and Zurzuvae™, both of which received FDA approval. His expertise spans neuroscience and RNA biology, with professional experience in corporate development, licensing, partnerships, drug discovery strategy, and capital raising.

Executive Officer, Director at Aldebaran Therapeutics

Intro paths

→

In turn, Carlos can intro founders to Aldebaran Therapeutics's investors below.

Aldebaran Therapeutics's investors · 1

Frazier Life SciencesPalo Alto · since 2022

Experience

  1. 82VSVenture Partner2024 — 2026Greater Boston
  2. 82VSExecutive In Residence2021 — 2024Cambridge, Massachusetts, United States
  3. Aldebaran TherapeuticsFounder & Board Member2022 — 2026Greater Boston
  4. Alloy Therapeutics, Inc.Head of Partnering | Genetic Medicines2024 — 2025Greater Boston
  5. Praxis Precision Medicines, Inc.Global Commercial Lead2020 — 2021Cambridge, Massachusetts, United States
  6. Praxis Precision Medicines, Inc.Director of Corporate Development2018 — 2021Cambridge, Massachusetts, United States
  7. Collegium Pharmaceutical, Inc.Associate Director of Corporate Development2016 — 2018Greater Boston
  8. inVentiv Health - Campbell AllianceEngagement Manager, Corporate Development & Strategy Practice2014 — 2016Greater Boston
  9. Sage TherapeuticsDrug Discovery and Porfolio Strategy2011 — 2014Cambridge, MA
  10. Third Rock VenturesConsultant2011Boston, MA
  11. Harvard Medical SchoolKirschstein & Ryan Graduate Research Fellow2005 — 2011Greater Boston
  12. Siemens Venture CapitalBusiness Analyst Intern2010Greater Boston

Skills & more

Lifesciences31Biotechnology39Genetics20Neuroscience23Biochemistry15Entrepreneurship12Genomics9Drug Discovery20Genetic EngineeringMarket Analysis4Venture Capital2RNAi
+12 moreBiopharmaceuticalsLife SciencesCell CultureCommercializationPharmacologyMolecular BiologyPharmaceutical IndustryClinical DevelopmentStrategyNegotiationBusiness DevelopmentFinance

Languages English · French · Spanish

From Carlos's professional profile.

Frequently asked questions

Who is Carlos Loya?
Carlos Loya is a scientist and biotech executive who served as a founding team member at SAGE Therapeutics and Praxis Precision Medicines, where he contributed to the strategy, discovery, and development of multiple programs including Zulresso™ and Zurzuvae™, both of which received FDA approval. His expertise spans neuroscience and RNA biology, with professional experience in corporate development, licensing, partnerships, drug discovery strategy, and capital raising.
Where did Carlos Loya go to school?
Carlos Loya studied at Harvard Medical School (PhD, Neurobiology); New Mexico State University (BS, Biochemistry); University of Lausanne - UNIL (BS, Biochemistry and French).

Founder mafias

Same school

Shared employers